查詢結果分析
來源資料
相關文獻
- Lansoprazole-Containing Triple Therapy on Helicobacter Pylori Associated Gastric Ulcers
- One-Week Low-Dose Triple Therapy is Effective in Treating Helicobacter Pylori-Infected Patients with Bleeding Peptic Ulcers
- Evaluation of Topographic Gastric Histology in H. Pylori Infection--A Comparative Study with CLO Test and Bacterial Culture
- 四君子湯抗精神壓力型胃潰瘍之研究
- 胃、十二指腸潰瘍的辨證論治
- Immunohistochemical Studies of Transforming Growth Factor-β and Its Receptors in the Gastric Mucosa of Patients with Refractory Gastric Ulcer
- One-Week Proton Pump Inhibitor-Based Triple Therapy Eradicates Residual Helicobacter Pylori after Failed Dual Therapy
- 豬脫肛和胃潰瘍之新病因研究報告和認識
- A Possible Protective Mechanism by Zinc Sulfate Against Ethanol-Induced Gastric Ulceration in Rats
- Changes of Gastric Mucosal Blood Flow in Gastric Ulcer Patients
頁籤選單縮合
題 名 | Lansoprazole-Containing Triple Therapy on Helicobacter Pylori Associated Gastric Ulcers=含有Lansoprazole之三合一療法對具有幽門螺旋菌感染的胃潰瘍之療效 |
---|---|
作 者 | 蔡東璣; 林憲宏; 黃呂津; 趙哲仁; 姚介和; 林肇堂; | 書刊名 | 慈濟醫學 |
卷 期 | 8:3 1996.09[民85.09] |
頁 次 | 頁191-196 |
分類號 | 415.526 |
關鍵詞 | 三合一療法; 胃潰瘍; 幽門螺旋菌; Lansoprazole; Triple therapy; Gastric ulcer; Helicobacter pylori; |
語 文 | 英文(English) |
中文摘要 | 幽門螺旋菌在消化性潰瘍扮演著致病原的角色,清除此菌可降低潰瘍復 發,但是目前並無一理想治療方案,質子幫浦抑制劑加上抗生素的治療法漸被重 視。本文報告1995年一月至十一月間,30個幽門螺旋菌陽性的胃潰瘍病人接受新 三合一療法(lansoprazole 30 mg bid,charithromycin 250 mg qid,amoxicillin 500 rng qid) 之結果。以此三合一療法治療二週,治療結束後四星期時,24例接受再評估,胃 潰瘍的癒合率為70.8(17/24),合併潰瘍縮小者則有91.6(22/24);潰瘍的延遲癒合與其 大小有顯著的相關,與幽門螺旋菌的持續存在並無相關;幽門螺旋菌的清除率為 66.7(16/24);20(6/30)的病人發生副作用 (腹瀉、掉髮、失眠、口腔潰瘍、噁心、口 乾、口麻、苦味感),但大多可被接受。此方案對潰瘍癒合及幽門螺旋菌的清除 有效,但要提高清除率則需注意病人遵囑性及細菌抗藥性。(慈濟醫學 1996;8:191-196) |
英文摘要 | Many regimens have been tried to eradicate Helicobacter pylori (Hp) in duodenal and gastriculcers. Lansoprazole, a new proton pump inhibitor, is effective as adjuvant therapy for Hp eradication.In this study, we evaluated the efficacy of a new triple therapy for Hp associated gastric ulcerscontaining two weeks of treatment with lansoprazole (30 mg bid), clarithromycin (250 mg qid), andamoxicillin (500 mg qid). Thirty patients were enrolled, of whom 24 completed the study. Four weeksafter completion of the regimen, follow up endoscopy revealed ulcer healing in 91.6 (22/24) ofpatients, with complete healing in 70.8 (17/24). The Hp eradication rate was 66.7 (16/24). Delayedhealing of the ulcers was significantly associated with the size of ulcer, but not with persistence of Hp.Six of 30 (20) patients experienced side effects, including diarrhea, alopecia, insomnia, an oral ulcer,nausea, dry mouth, numbness, and bitter sensation. In conclusion, lansoprazole triple therapy iseffective for Hp eradication in gastric ulcers. For a higher eradication rate, patient compliance anddrug resistance should be further studied. (Tzu Chi MedJ 1996; 8: 191-196) |
本系統中英文摘要資訊取自各篇刊載內容。